ReviewCureus2022

The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors.

Lorenzo Di Spazio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.